ArticlePloS one2026

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial.

Sergio Sequera-Arquelladas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.